中文 | English
Return
Total: 20 , 1/2
Show Home Prev Next End page: GO
Author:(Zhenghong QIN)

1.Matrix metalloproteinases and nervous diseases

Chao WEI ; Zhenghong QIN ; Huiling ZHANG

Chinese Pharmacological Bulletin 1987;0(01):-

2.Neuroprotective Actions and Possible Underlying Molecular Mechanisms of Valproate

Lingyun LI ; Zhenghong QIN ; Zhongqin LIANG

Chinese Pharmacological Bulletin 1987;0(03):-

3.Chronic subcutaneous injection of rotenone produces rodent Parkinsonian models

Xilin ZHAO ; Zhenlun GU ; Zhenghong QIN

Chinese Pharmacological Bulletin 2003;0(10):-

4.Peroxisome prolifreator-activated receptors and neurodegenerative diseases

Huiling ZHANG ; Zhenlun GU ; Zhenghong QIN

Chinese Pharmacological Bulletin 1986;0(04):-

5.Research progress in molecular pathology of Huntington's disease

Zhenghong QIN ; Zhenlun GU ; Fang LIN ;

Chinese Pharmacological Bulletin 1986;0(04):-

6.The value of supplement of recombinational Tth-single strand binding protein in polymerase chain reaction for genotyping

Shuting YANG ; Jin WANG ; Zhenghong QIN ; Bin ZHU

Chinese Journal of Laboratory Medicine 2012;35(3):233-236

8.The role of autophagy in cell survival and tumor development

Cihui YAN ; Zhongqin LIANG ; Zhenlun GU ; Zhenghong QIN

Chinese Pharmacological Bulletin 1987;0(03):-

9.The research progress of cobra venom secretory phospholipase A_2

Yaping YANG ; Zhongqin LIANG ; Zhenlun GU ; Zhenghong QIN

Chinese Pharmacological Bulletin 2003;0(09):-

10.Role of mitochondrial aldehyde dehydrogenase 2 in postconditioning induced cardioprotection

Qin GAO ; Cuirong JIANG ; Ying YU ; Jie HU ; Zhenghong LI ; Sudong GUAN

Chinese Pharmacological Bulletin 2003;0(08):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 20 , 1/2 Show Home Prev Next End page: GO